Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Porter

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Journal of the American Academy of Child and Adolescent Psychiatry|June 30, 2022
An Innovative Model of Pediatric Emergency Department Mental Health Care: Protocol for a Multicenter Type 1 Effectiveness-Implementation Cluster Randomized TrialAmanda S Newton, Kassi Prisnie, Lee A Macdonald, et al.
The Journal of Pediatrics|January 8, 2021
Predicting Adverse Outcomes for Shiga Toxin-Producing Escherichia coli Infections in Emergency DepartmentsChu Yang Lin, Jianling Xie, Stephen B Freedman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2019
Predicting Hemolytic Uremic Syndrome and Renal Replacement Therapy in Shiga Toxin-producing Escherichia coli-infected ChildrenRyan S McKee, David Schnadower, Phillip I Tarr, et al.
The Lancet. Infectious Diseases|October 7, 2022
Antibiotic review kit for hospitals (ARK-Hospital): a stepped-wedge cluster-randomised controlled trialMartin J Llewelyn, Eric P Budgell, Magda Laskawiec-Szkonter, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Journal of the American Academy of Child and Adolescent Psychiatry|June 30, 2022
An Innovative Model of Pediatric Emergency Department Mental Health Care: Protocol for a Multicenter Type 1 Effectiveness-Implementation Cluster Randomized TrialAmanda S Newton, Kassi Prisnie, Lee A Macdonald, et al.
The Journal of Pediatrics|January 8, 2021
Predicting Adverse Outcomes for Shiga Toxin-Producing Escherichia coli Infections in Emergency DepartmentsChu Yang Lin, Jianling Xie, Stephen B Freedman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2019
Predicting Hemolytic Uremic Syndrome and Renal Replacement Therapy in Shiga Toxin-producing Escherichia coli-infected ChildrenRyan S McKee, David Schnadower, Phillip I Tarr, et al.
The Lancet. Infectious Diseases|October 7, 2022
Antibiotic review kit for hospitals (ARK-Hospital): a stepped-wedge cluster-randomised controlled trialMartin J Llewelyn, Eric P Budgell, Magda Laskawiec-Szkonter, et al.
Pageof 7